Preparation and characterisation of the colistin-entrapped liposome driven by electrostatic interaction for intravenous administration

References

• Alipour M, Halwani M, Omri A, Suntres ZE. Antimicrobial effectiveness of liposomal polymyxin B against resistant Gram-negative bacterial strains. Int J Pharm, 2008;355:293–8.
   PubMed Web of Science ®Google Scholar
• Bakker-Woudenberg I. Long-circulating sterically stabilized liposomes as carriers of agents for treatment of infection or for imaging infectious foci. Int J Antimicrob Agents, 2002;19:299–311.
   PubMed Web of Science ®Google Scholar
• Barenholz Y. Doxil®-the first FDA-approved nano-drug: Lessons learned. J Control Release, 2012;160:117–34.
   PubMed Web of Science ®Google Scholar
• Caracciolo G, Amenitsch H. Cationic liposome/DNA complexes: From structure to interactions with cellular membranes. Eur Biophys J, 2012;41:815–29.
   PubMed Web of Science ®Google Scholar
• Caracciolo G, Pozzi D, Caminiti R, Amenitsch H. Formation of overcharged cationic lipid/DNA complexes. Chem Phys Lett, 2006;429:250–4.
   Web of Science ®Google Scholar
• Drulis-Kawa Z, Dorotkiewicz-Jach A. Liposomes as delivery systems for antibiotics. Int J Pharm, 2010;387:187–98.
   PubMed Web of Science ®Google Scholar
• Dudhani RV, Turnidge JD, Coulthard K, Milne RW, Rayner CR, Li J, Nation RL. Elucidation of the pharmacokinetic/pharmacodynamic determinant of colistin activity against Pseudomonas aeruginosa in murine thigh and lung infection models. Antimicrob Agents Chemother, 2010a;54:1117–24.
   PubMed Web of Science ®Google Scholar
• Dudhani RV, Turnidge JD, Nation RL, Li J. fAUC/MIC is the most predictive pharmacokinetic/pharmacodynamic index of colistin against Acinetobacter baumannii in murine thigh and lung infection models. J Antimicrob Chemother, 2010b;65:1984–90.
   PubMed Web of Science ®Google Scholar
• Halwani M, Mugabe C, Azghani AO, Lafrenie RM, Kumar A, Omri A. Bactericidal efficacy of liposomal aminoglycosides against Burkholderia cenocepacia. J Antimicrob Chemother, 2007;60:760–9.
   PubMed Web of Science ®Google Scholar
• He H, Li JC, Nation RL, Jacob J, Chen G, Lee HJ, Tsuji BT, Thompson PE, Roberts K, Velkov T, Li J. Pharmacokinetics of four different brands of colistimethate and formed colistin in rats. J Antimicrob Chemother, 2013;68:2311–17.
   PubMed Web of Science ®Google Scholar
• Israelachvili JN. 2011. Intermolecular and surface forces: revised third edition. New York: Academic Press.
   Google Scholar
• Jung SH, Jung SH, Seong H, Cho SH, Jeong KS, Shin BC. Polyethylene glycol-complexed cationic liposome for enhanced cellular uptake and anticancer activity. Int J Pharm, 2009;382:254–61.
   PubMed Web of Science ®Google Scholar
• Kwa A, Kosiakou SK, Tam VH, Falagas ME. Polymyxin B: Similarities to and differences from colistin (polymyxin E). Expert Rev Anti-Infect Ther, 2007;5:811–21.
   PubMed Web of Science ®Google Scholar
• Lawrence SM, Alpar HO, Mcallister SM, Brown MR. Liposomal (MLV) polymyxin B: Physicochemical characterization and effect of surface charge and drug association. J Drug Target, 1993;1:303–10.
   PubMed Web of Science ®Google Scholar
• Li J, Nation RL, Turnidge JD, Milne RW, Coulthard K, Rayner CR, Paterson DL. Colistin: The re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect Dis, 2006;6:589–601.
   PubMed Web of Science ®Google Scholar
• Li Y, Yang L. Driving forces for drug loading in drug carriers. J Microencapsul, 2015;2:1–18.
   Google Scholar
• Marr AK, Gooderham WJ, Hancock REW. Antibacterial peptides for therapeutic use: Obstacles and realistic outlook. Curr Opin Pharmacol, 2006;6:468–72.
   PubMed Web of Science ®Google Scholar
• Mcallister SM, Alpar HO, Brown MR. Antimicrobial properties of liposomal polymyxin B. J Antimicrob Chemother, 1999;43:203–10.
   PubMed Web of Science ®Google Scholar
• Mokhtarieh AA, Cheong S, Kim S, Chung BH, Lee MK. Asymmetric liposome particles with highly efficient encapsulation of siRNA and without nonspecific cell penetration suitable for target-specific delivery. Biochim Biophys Acta Biomembr, 2012;1818:1633–41.
   PubMed Web of Science ®Google Scholar
• Ong ZY, Wiradharma N, Yang YY. Strategies employed in the design and optimization of synthetic antimicrobial peptide amphiphiles with enhanced therapeutic potentials. Adv Drug Deliv Rev, 2014;78:28–45.
   PubMed Web of Science ®Google Scholar
• Sani MA, Whitwell TC, Separovic F. Lipid composition regulates the conformation and insertion of the antimicrobial peptide maculatin 1.1. Biochim Biophys Acta Biomembr, 2012;1818:205–11.
   PubMed Web of Science ®Google Scholar
• Sarkar S, Desantis ER, Kuper J. Resurgence of colistin use. Am J Health Syst Pharm, 2007;64:2462–6.
   PubMed Web of Science ®Google Scholar
• Schiffelers RM, Bakker-Woudenberg IA, Snijders SV, Storm G. Localization of sterically stabilized liposomes in Klebsiella pneumoniae-infected rat lung tissue: Influence of liposome characteristics. Biochim Biophys Acta, 1999;1421:329–39.
   PubMed Web of Science ®Google Scholar
• Schiffelers RM, Storm G, Ten Kate MT, Bakker-Woudenberg IA. Therapeutic efficacy of liposome-encapsulated gentamicin in rat Klebsiella pneumoniae pneumonia in relation to impaired host defense and low bacterial susceptibility to gentamicin. Antimicrob Agents Chemother, 2001;45:464–70.
   PubMed Web of Science ®Google Scholar
• Simoes S, Moreira JN, Fonseca C, Duzgunes N, De Lima MCP. On the formulation of pH-sensitive liposomes with long circulation times. Adv Drug Deliv Rev, 2004;56:947–65.
   PubMed Web of Science ®Google Scholar
• Stuart DD, Allen TM. A new liposomal formulation for antisense oligodeoxynucleotides with small size, high incorporation efficiency and good stability. Biochim Biophys Acta, 2000;1463:219–29.
   PubMed Web of Science ®Google Scholar
• Teixeira V, Feio MJ, Bastos M. Role of lipids in the interaction of antimicrobial peptides with membranes. Prog Lipid Res, 2012;51:149–77.
   PubMed Web of Science ®Google Scholar
• Wallace SJ, Li J, Nation RL, Prankerd RJ, Boyd BJ. Interaction of colistin and colistin methanesulfonate with liposomes: Colloidal aspects and implications for formulation. J Pharm Sci, 2012;101:3347–59.
   PubMed Web of Science ®Google Scholar
• Wang D, Kong L, Wang J, He X, Li X, Xiao Y. Polymyxin E sulfate-loaded liposome for intravenous use: Preparation, lyophilization, and toxicity assessment in vivo. PDA J Pharm Sci Technol/PDA, 2009;63:159–67.
   PubMedGoogle Scholar
• Wang X, Deng L, Chen X, Pei H, Cai L, Zhao X, Wei Y, Chen L. Truncated bFGF-mediated cationic liposomal paclitaxel for tumor-targeted drug delivery: Improved pharmacokinetics and biodistribution in tumor-bearing mice. J Pharm Sci, 2011;100:1196–205.
   PubMed Web of Science ®Google Scholar
• Wessman P, Stromstedt AA, Malmsten M, Edwards K. Melittin-lipid bilayer interactions and the role of cholesterol. Biophys J, 2008;95:4324–36.
   PubMed Web of Science ®Google Scholar
• Wiese A, Munstermann M, Gutsmann T, Lindner B, Kawahara K, Zahringer U, Seydel U. Molecular mechanisms of polymyxin B-membrane interactions: Direct correlation between surface charge density and self-promoted transport. J Membrane Biol, 1998;162:127–38.
   PubMed Web of Science ®Google Scholar
• Woodle MC, Collins LR, Sponsler E, Kossovsky N, Papahadjopoulos D, Martin FJ. Sterically stabilized liposomes. Reduction in electrophoretic mobility but not electrostatic surface potential. Biophys J, 1992;61:902–10.
   PubMed Web of Science ®Google Scholar
• Xu H, Deng Y, Chen D, Hong W, Lu Y, Dong X. Esterase-catalyzed dePEGylation of pH-sensitive vesicles modified with cleavable PEG-lipid derivatives. J Control Release, 2008;130:238–45.
   PubMed Web of Science ®Google Scholar
• Yahav D, Farbman L, Leibovici L, Paul M. Colistin: New lessons on an old antibiotic. Clin Microbiol Infect, 2012;18:18–29.
   PubMed Web of Science ®Google Scholar
• Yamauchi M, Kusano H, Saito E, Iwata T, Nakakura M, Kato Y, Aoki N. Development of wrapped liposomes: Novel liposomes comprised of polyanion drug and cationic lipid complexes wrapped with neutral lipids. Biochim Biophys Acta Biomembr, 2006;1758:90–7.
   PubMed Web of Science ®Google Scholar
• Yang YY. Emergence of multidrug-resistant bacteria: Important role of macromolecules and drug delivery systems. Adv Drug Deliv Rev, 2014;78:1–2.
   PubMed Web of Science ®Google Scholar
• Yeaman MR, Yount NY. Mechanisms of antimicrobial peptide action and resistance. Pharmacol Rev, 2003;55:27–55.
   PubMed Web of Science ®Google Scholar
• Yu Z, Qin W, Lin J, Fang S, Qiu J. Antibacterial mechanisms of polymyxin and bacterial resistance. BioMed Res Int, 2015;2015:679109.
   PubMed Web of Science ®Google Scholar